The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

30 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of aryl-biphenyl-2-ylmethylpiperazines as novel scaffolds for 5-HT(7) ligands and role of the aromatic substituents in binding to the target receptor.EBI
Institute of Science and Technology
Synthesis and biological evaluation of oxazole derivatives as T-type calcium channel blockers.EBI
Institute of Science and Technology
Indirubin derivatives as potent FLT3 inhibitors with anti-proliferative activity of acute myeloid leukemic cells.EBI
Institute of Science and Technology
Aminostyrylbenzofuran derivatives as potent inhibitors for Abeta fibril formation.EBI
Institute of Science and Technology
Novel quinazolinone derivatives as 5-HT7 receptor ligands.EBI
Institute of Science and Technology
Design, synthesis, and biological evaluation of 1,3-dioxoisoindoline-5-carboxamide derivatives as T-type calcium channel blockers.EBI
Institute of Science and Technology
Structure-activity relationship studies of spinorphin as a potent and selective human P2X(3) receptor antagonist.EBI
Institute of Science and Technology
Design and synthesis of a piperazinylalkylisoxazole library for subtype selective dopamine receptor ligands.EBI
Institute of Science and Technology
Synthesis and HIV-1 integrase inhibitory activities of caffeoylglucosides.EBI
Institute of Science and Technology
Facile synthesis and biological evaluation of 3,3-diphenylpropanoyl piperazines as T-type calcium channel blockers.EBI
Institute of Science and Technology
Synthesis of aminoquinazoline derivatives and their antiproliferative activities against melanoma cell line.EBI
Institute of Science and Technology
IKKbeta inhibitors identification part II: ligand and structure-based virtual screening.EBI
Institute of Science and Technology
Design and synthesis of new potent anticancer pyrazoles with high FLT3 kinase inhibitory selectivity.EBI
Institute of Science and Technology
Design and synthesis of 1,4-dihydropyridine derivatives as BACE-1 inhibitors.EBI
Institute of Science and Technology
1,4-dihydropyrazolo[4,3-d]imidazole phenyl derivatives: a novel type II Raf kinase inhibitors.EBI
Institute of Science and Technology
Discovery of a new potent bisamide FMS kinase inhibitor.EBI
Institute of Science and Technology
Synthesis and biological evaluation of 1,4-diazepane derivatives as T-type calcium channel blockers.EBI
Institute of Science and Technology
5,5'-substituted indirubin-3'-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity.EBI
Institute of Science and Technology
Identification of novel serotonin 2C receptor ligands by sequential virtual screening.EBI
Institute of Science and Technology
HIF-1alpha peptide derivatives with modifications at the hydroxyproline residue as activators of HIF-1alpha.EBI
Institute of Science and Technology
Structure-activity relationships of heteroaromatic esters as human rhinovirus 3C protease inhibitors.EBI
Institute of Science and Technology
IKKbeta inhibitors identification part I: homology model assisted structure based virtual screening.EBI
Institute of Science and Technology
Synthesis of tyrosinase inhibitory (4-oxo-4H-pyran-2-yl)acrylic acid ester derivatives.EBI
Institute of Science and Technology
Synthesis and evaluation of alpha,alpha'-disubstituted phenylacetate derivatives for T-type calcium channel blockers.EBI
Institute of Science and Technology
Synthesis and structure-activity relationship studies of tyrosine-based antagonists at the human P2X7 receptor.EBI
Institute of Science and Technology
Lead discovery and optimization of T-type calcium channel blockers.EBI
Institute of Science and Technology
3D pharmacophore based virtual screening of T-type calcium channel blockers.EBI
Institute of Science and Technology
Novel T-type calcium channel blockers: dioxoquinazoline carboxamide derivatives.EBI
Institute of Science and Technology
Morpholin-2-one derivatives as novel selective T-type Ca2+ channel blockers.EBI
Institute of Science and Technology
Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.EBI
Institute of Science and Technology